PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
This new fund is amongst the largest for the sector in India
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year
The facility is among 12 centres established worldwide, and the first in Asia
Under the terms of the agreement, Bachem will provide the appropriate engineering infrastructure and expertise to implement Lilly’s novel oligonucleotide manufacturing technology
All the capex is being met through internal accruals only
Subscribe To Our Newsletter & Stay Updated
